DGAP-News: MPH Mittelständische Pharma Holding AG / Key word(s): Quarter Results/Development of Sales MPH Mittelständische Pharma Holding AG: 1st Quarter 2013: +31.4% in Sales; +34.3% in EBIT 23.05.2013 / 08:15 --------------------------------------------------------------------- MPH Mittelständische Pharma Holding AG: 1st Quarter 2013: +31.4% in Sales; +34.3% in EBIT For the first three months of the current year, the Group is reporting sales of EUR 53.42 million, with thus representing an increase of 31.4 % compared to the same period of the previous year (prior-year period: EUR 40.66 million). The consolidated profit before interests and taxes (EBIT) for January through March 2013, at EUR 4.15 million, was 34.3 % above the prior-year level (EUR 3.09 million). An EBIT margin of 7.8% was achieved. About MPH Mittelständische Pharma Holding AG: The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on growth segments Pharma and Healthcare. On the basis of patent-free and patent-protected active substances, production and consultancy services for therapies of chronic diseases, the Group makes a precious contribution to keeping health affordable. MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) of the Frankfurt stock exchange. Key figures for the share of MPH Mittelständische Pharma Holding AG: Subscribed capital: EUR 41.167.155 Listed shares: Preference shares Number of preference shares in circulation: 19.025.000 ISIN: DE000A0NF697 WKN: A0NF69 Stock symbol: 93MV Contact: Linda Reichelt MPH Mittelständische Pharma Holding AG FasanenstraÃe 77 D-10623 Berlin Tel:+49 (0) 30 897308660 Fax:+49 (0) 30 897308670 E-Mail: ir@mph-ag.de Web: www.mph-ag.de End of Corporate News --------------------------------------------------------------------- 23.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: MPH Mittelständische Pharma Holding AG FasanenstraÃe 77 10623 Berlin Germany Phone: 030 / 897 308 660 Fax: 030 / 897 308 670 E-mail: info@mph-ag.de Internet: www.mph-ag.de ISIN: DE000A0NF697 WKN: A0NF69 Listed: Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in Open Market (Entry Standard) End of News DGAP News-Service --------------------------------------------------------------------- 212404 23.05.2013
DGAP-News: MPH Mittelständische Pharma Holding AG: 1st Quarter 2013: +31.4% in Sales; +34.3% in EBIT
| Source: EQS Group AG